OncoSec Medical Inc. (ONCS) - Product Pipeline Analysis, 2013 Update - New Market Research Report
OncoSec Medical Inc. (OncoSec) is a biotechnology service provider. The company provides treatments for skin cancer. Its treatments include Immunepulse and Neopulse. OncoSec's Immunepulse uses body's immune system to target local and metastasized cancer cells. Immunepulse also utilizes OMS system to deliver DNA IL-12 into the electroporated cells. The company's Neopulse uses the OMS system to destroy cancer cells. Its technology platform is based on electroporation that is a process, which opens temporary pores in the cell membrane of infected...
View full press release